by Annie De Groot | Jan 31, 2020 | Events
Dr. Anne De Groot CEO/CSO with Dr. Patricia Bettinger, the Scientific Director of EpiVax’s Tregitope program, will be attending the 3rd Annual Antigen-Specific Immune Tolerance Drug Development meeting in Boston, MA from February 25-27, 2020. Annie will...
by Annie De Groot | Feb 26, 2019 | Events
2nd Antigen-Specific Immune Tolerance Drug Development Summit Tuesday, March 26th – Thursday, March 28th, 2019 Wyndham Boston Beacon Hill 5 Blossom Street Boston, Massachusetts 02114 USA Join Dr. Annie De Groot, CEO/CSO EpiVax, at the 2nd Antigen-Specific Immune...
